Legend:

• Concept Types
  • target (pathway-based classification term)
  • classification term
  • pathway-based classification term
  • clinical findings
  • multiple types disease
  • single disease
  • disease type

'Other sphingolipidosis'  (Integration tree)

Pathogenesis

• Genetic disorders of glycan degradation
  • Disorders of sphingolipid metabolism and other lipid storage disorders
    • Sphingolipidosis
      • Other sphingolipidosis
        • Fabry disease (GDGDB) [GLA]
        • Gaucher disease
          • Gaucher disease, type I (GDGDB) [GBA]
          • Gaucher disease, type II (GDGDB) [GBA]
            • Gaucher disease, type II, neuronopathic form, classic type [GBA]
            • Gaucher disease, type II, perinatal lethal form [GBA]
          • Gaucher disease, type III (GDGDB) [GBA]
          • Gaucher disease, type IIIC (GDGDB) [GBA]
          • Gaucher disease, atypical, due to saposin C deficiency (GDGDB) [PSAP]
        • Krabbe disease (GDGDB) [GALC]
          • Krabbe disease, infantile form [GALC]
          • Krabbe disease, late-onset form [GALC]
        • Sulfatidosis
          • Multiple sulfatase deficiency (GDGDB) [SUMF1]
          • Metachromatic leukodystrophy
            • Metachromatic leukodystrophy (GDGDB) [ARSA]
              • Metachromatic leukodystrophy, infantile form [ARSA]
              • Metachromatic leukodystrophy, juvenile form [ARSA]
              • Metachromatic leukodystrophy, adult form [ARSA]
            • Metachromatic leukodystrophy, due to saposin B deficiency (GDGDB) [PSAP]
        • Niemann-Pick disease
          • Niemann-Pick disease, type A (GDGDB) [SMPD1]
          • Niemann-Pick disease, type B (GDGDB) [SMPD1]
          • Niemann-Pick disease, type C
            • Niemann-Pick disease, type C1 (GDGDB) [NPC1]
            • Niemann-Pick disease, type C2 (GDGDB) [NPC2]
        • Farber Lipogranulomatosis (GDGDB) [ASAH1]
          • Farber Lipogranulomatosis, type 1 [ASAH1]
          • Farber Lipogranulomatosis, type 2 [ASAH1]
          • Farber Lipogranulomatosis, type 3 [ASAH1]
          • Farber Lipogranulomatosis, type 4 [ASAH1]
          • Farber Lipogranulomatosis, type 5 [ASAH1]

Disorders by systems

• Genetic disorders of glycan degradation (by systems, signs and symptoms)